Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CARDINAL HEALTH, INC.

(CAH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Cardinal Health : Cancer Test Approved for Use in Children by US FDA

06/10/2021 | 07:56am EDT


ę MT Newswires 2021
All news about CARDINAL HEALTH, INC.
07/28CARDINAL HEALTH : Trial against opioid distributors wraps up in West Virginia
AQ
07/27W. Va. city, drug distributors trade final words in landmark opioid trial
RE
07/27AMERISOURCEBERGEN : Closing arguments held in West Virginia lawsuit over opioids
AQ
07/27Frontline advocates view $26 billion opioid deal with frustration, worry
RE
07/22ENDO INTERNATIONAL : Drugmaker Endo settles opioid claims by Tennessee counties,..
RE
07/22CARDINAL HEALTH : DISTRIBUTORS ANNOUNCE PROPOSED OPIOID SETTLEMENT AGREEMENT (Fo..
PU
07/22CARDINAL HEALTH INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
07/21U.S. state officials urge support for landmark $26 billion opioid settlement
RE
07/21CARDINAL HEALTH : States reach $26B opioid settlement with Johnson & Johnson, 'b..
AQ
07/21Health Care Flat As Traders Hedge On Growth View -- Health Care Roundup
DJ
More news
Financials (USD)
Sales 2021 160 B - -
Net income 2021 652 M - -
Net Debt 2021 3 091 M - -
P/E ratio 2021 26,8x
Yield 2021 3,31%
Capitalization 17 229 M 17 229 M -
EV / Sales 2021 0,13x
EV / Sales 2022 0,11x
Nbr of Employees 48 000
Free-Float 88,8%
Chart CARDINAL HEALTH, INC.
Duration : Period :
Cardinal Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARDINAL HEALTH, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Last Close Price 59,38 $
Average target price 62,08 $
Spread / Average Target 4,54%
EPS Revisions
Managers and Directors
Michael C. Kaufmann Chief Executive Officer & Director
Jason M. Hollar Chief Financial Officer
Gregory B. Kenny Independent Non-Executive Chairman
Brian S. Rice Chief Information Officer & Executive VP
Jessica L. Mayer Chief Compliance & Legal Officer
Sector and Competitors